本文へ移動
cccskills
無料GitHub で公開

es-pump-basal-rate-adaptation

Considers adapting the basal insulin rate at hospital admission for patients using insulin pump therapy. Triggered by clinician questions such as "Should we adjust the basal rate upon admission for pump therapy?" or when evaluating pump continuation versus transition to scheduled subcutaneous insulin.

dromlakhani/MD2SKILL
インストール方法を見る

含まれるファイル（1）

  • SKILL.md3.5 KB

SKILL.md（原文）

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Adapt basal insulin rate at time of admission for insulin pump patients

STEP 1 — Gather Information

Collect current pump settings (basal profile, total daily dose, insulin‑to‑carb ratio, correction factor), recent glucose trends (last 12‑24 h CGM or SMBG), admission diagnosis, anticipated hospital length of stay, patient’s ability to self‑manage the pump, and any factors that may interrupt pump use (e.g., impaired consciousness, NPO status, need for MRI, vasopressors).
Action: Proceed to assess suitability for pump continuation.

STEP 2 — Rule In / Rule Out

Determine if the hospital has personnel with expertise in insulin pump therapy and the patient can safely self‑manage the pump.

  • Yes: Continue insulin pump therapy; move to Step 3.
  • No: Plan transition to scheduled subcutaneous basal‑bolus insulin before pump discontinuation (per guideline for anticipated LOS > 1‑2 days).
    Decision: Either continue pump or prepare for transition.

STEP 3 — Classify or Stratify

For patients continuing pump, evaluate need for basal rate adjustment:

  • If TDD ≥ 0.6 U/kg, recent hypoglycemia, or expected increased insulin resistance (infection, steroids) → consider basal reduction (10‑20%).
  • If anticipated decreased insulin needs (NPO, reduced caloric intake) → consider basal reduction as above.
  • If persistent hyperglycemia despite current settings → consider basal increase (5‑10%).
  • Otherwise, retain current basal rates.
    Decision: Determine the basal rate adjustment percentage to apply at admission.

STEP 4 — Decide

Program the pump with the adjusted basal rate (or calculate equivalent basal dose for SC BBI if transitioning). Write an order specifying the new basal rate, frequency of glucose checks (CGM or POC‑BG q1‑2 h initially), and plan for reassessment every 4‑6 h or with clinical change.
Action: Implement adjusted basal rate and initiate glucose monitoring.

Clinical Guardrails / Mimics / Pitfalls

  • Do not adjust basal rates without verifying pump functionality and patient competence.
  • Avoid making changes if the pump will be interrupted by procedures (MRI, CT) without a plan to revert to manual mode.
  • Never rely solely on pump‑reported glucose; confirm with point‑of‑care measurements before dosing changes.
  • Do not discontinue pump without having a ready subcutaneous insulin regimen to prevent DKA.

Concrete Clinical Example

A 58‑year‑old with type 1 diabetes on pump (basal 0.8 U/hr, TDD 0.55 U/kg) is admitted for cellulitis with expected LOS 3 days; pump expertise is available and the patient is competent. Recent glucose trends show mild hyperglycemia (150‑180 mg/dL). The team decides to reduce the basal rate by 10 % to 0.72 U/hr at admission, initiates CGM/POC‑BG checks q1 h, and plans to reassess the basal rate q6 h or with glucose changes.

Source: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, https://doi.org/10.1210/clinem/dgac278

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

ログインしてレビューを書く

同じリポジトリのスキル

概要と使いどころ

780g-pump-adjustment

無料

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-acth-stim-test-interpretation

無料

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-adrenal-crisis-treatment

無料

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-ai-education

無料

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-lt4-monitoring

無料

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-cortisol-cutoff-ai-diagnosis

無料

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する